Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Assisted Reproductive Technology Market In The Coming Years?
The market size for assisted reproductive technology has seen impressive growth lately. A rise from $34.35 billion in 2024 to $37.06 billion in 2025 is anticipated, showcasing a compound annual growth rate (CAGR) of 7.9%. Factors contributing towards such growth during the historical period include a rise in infertility rates, evolvement of societal norms, enhanced awareness, legislative backing, and an upsurge in the aging population.
The market size for assisted reproductive technology is predicted to exhibit robust expansion in the following years, culminating in a value of $52.42 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.1%. The projected growth during this forecast period is linked to various factors such as the increase in maternal age, a growing need for same-sex parenting, the rise in medical tourism, the widening healthcare infrastructure, and research and development activities. Anticipated trends for this period encompass the utilization of artificial intelligence (AI), egg preservation, single-embryo transfer (SET), PGT-A and genetic screening, as well as novel fertility preservation methods.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5489&type=smp
Which Growth Drivers Are Shaping The Assisted Reproductive Technology Market Outlook?
The surge in infertility is anticipated to have a positive impact on the growth of the assisted reproductive technology market in the upcoming years. Infertility, which impacts both genders, is characterized by the inability to conceive after a year of regular unprotected intercourse. Assisted reproductive technology (ART), which includes therapies using both female and male reproductive cells, is used as a treatment for infertility. For instance, the World Health Organization (WHO), a Switzerland-based global health institution, forecasted that millions of the globally reproductive age population will face infertility issues in April 2023. This will further affect their families and societies at large. It’s projected that approximately 1 in 6 adults worldwide, accounting for around 17.5% of the total adult population globally, battles with infertility. Consequently, the increasing incidents of infertility are catalyzing the expansion of the assisted reproductive technology market.
What Is The Segment Breakdown Of The Assisted Reproductive Technology Market?
The assisted reproductive technologymarket covered in this report is segmented –
1) By Diagnosis: Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing
2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo Or Egg Banking
3) By End-User: Hospitals; Fertility Clinics; Other End-Users
Subsegments:
1) By Ovulation Testing: Urine Ovulation Predictor Kits; Saliva Ovulation Test Kits
2) By Hysterosalpingography (HSG): X-ray HSG; Sonohysterography (SHG)
3) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing; Anti-Müllerian Hormone (AMH) Testing; Antral Follicle Count (AFC) via Ultrasound
4) By Genetic Testing: Preimplantation Genetic Testing (PGT); Carrier Screening Tests; Genetic Compatibility Testing
How Are Global Trends Impacting The Development Of The Assisted Reproductive Technology Market?
One major trend gaining traction in the assisted reproductive technology market is the advancement of technology. The primary companies in this field are diligently working on creating technological solutions to solidify their market standing. For example, Alife Health, an American medical equipment production company, launched the Alife Assist platform in October 2022. This suite of products aims to modernize the in-vitro fertilization (IVF) procedure through the use of data-driven insights and artificial intelligence (AI). It offers assistance to all facets of the IVF process, including clinical decision-making, clinic administration, and various key stages of the IVF process. The platform includes Stim Assist, Embryo Assist, and Insights, providing extensive support to reproductive endocrinologists, embryologists, and clinic administrators. It helps enhance medication dosing, embryo grading, and real-time performance monitoring, ultimately improving the patient’s experiences and the success of IVF treatments.
Who Are The Major Stakeholders Operating In The Assisted Reproductive Technology Market?
Major companies operating in the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Boston Scientific Corporation, Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Assisted Reproductive Technology Market?
Europe was the largest region in the assisted reproductive technology market in 2024. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=5489&type=smp
Browse Through More Reports Similar to the Global Assisted Reproductive Technology Market 2025, By The Business Research Company
Prenatal Testing And Newborn Screening Global Market Report 2025
Fertility Treatments Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Fertility Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
